Effects of angiopoietin-1 on inflammatory injury in endothelial progenitor cells and blood vessels

Current Gene Therapy

Volumn 14, Issue 2, 2014, Pages 128-135

  Wang, Yi Qing ^a   Song, Jing Jin ^a   Han, Xiao ^a   Liu, Yi Ye ^a   Wang, Xi Huang ^a   Li, Zhi ming ^b   Tzeng, Chi Meng ^b  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Angiopoietin 1; Carotid balloon catheter injury; Endothelial progenitor cells; Inflammation

Indexed keywords

ANGIOPOIETIN 1; CD34 ANTIGEN; CYCLINE; INTERCELLULAR ADHESION MOLECULE 1; LENTIVIRUS VECTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL INJURY; CELL CULTURE; CELL EXPANSION; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL BALLOON CATHETER INJURY; FEMORAL ARTERY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HISTOLOGY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; ANIMAL; BLOOD VESSEL; CELL SURVIVAL; GENE THERAPY; GENE VECTOR; GENETIC TRANSCRIPTION; GENETICS; LENTIVIRINAE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PROCEDURES; SPRAGUE DAWLEY RAT; VIROLOGY;

ANGIOPOIETIN-1; ANIMALS; BLOOD VESSELS; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL PROGENITOR CELLS; GENETIC THERAPY; GENETIC VECTORS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LENTIVIRUS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84904472167     PISSN: 15665232     EISSN: 18755631     Source Type: Journal    
DOI: 10.2174/1566523214666140307111138     Document Type: Article

References (26)

1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
2. Suda T, Takakura N, Oike Y. Hematopoiesis and angiogenesis. Int J Hematol, 2000; 71: 99-107.
3. Liew A, Barry F, O'Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 2006; 28: 261-70.
4. Loughna S, Sato TN. Angiopoietin and Tie signaling pathways in vascular development. Matrix Biol 2001; 20: 319-25.
5. Kinnaird T, Stabile E, Zbinden S, Burnett MS, Epstein SE. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovasc Res 2008; 78: 257-64.
6. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998; 282: 468-71.
7. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732-8.
8. Nabel EG. Stem cells combined with gene transfer for therapeutic vasculogenesis: magic bullets? Circulation 2002; 105: 672-4.
9. Eggermann J, Kliche S, Jarmy G, et al. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 2003; 58: 478-86.
10. Ausubel FM, Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith JAS, K. (eds) Current protocols in molecular biology, 2004: 8-16.
11. Thomas M, Augustin HG. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 2009; 12: 125-37.
12. Ma ZL, Mai XL, Sun JH, et al. Inhibited atherosclerotic plaque formation by local administration of magnetically labeled endothelial progenitor cells (EPCs) in a rabbit model. Atherosclerosis 2009; 205: 80-6.
13. Han W, Liu GN. EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of ballooninjured arteries in rat. Life Sci 2010; 86: 234-43.
14. Ii M. Bone marrow-derived endothelial progenitor cells: isolation and characterization for myocardial repair. Methods Mol Biol 2010; 660: 9-27.
15. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-8.
16. Sheu JR, Wu CH, Chen YC, Hsiao G, Lin CH. Mechanisms in the inhibition of neointimal hyperplasia with triflavin in a rat model of balloon angioplasty. J Lab Clin Med 2001; 137: 270-8.
17. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004; 35: 2378-84.
18. Zhang S, Zhao L, Shen L, et al. Comparison of various niches for endothelial progenitor cell therapy on ischemic myocardial repair: coexistence of host collateralization and Akt-mediated angiogenesis produces a superior microenvironment. Arterioscler Thromb Vasc Biol 2012; 32: 910-23.
19. Lever AM, Strappe PM, Zhao J. Lentiviral vectors. J Biomed Sci 2004; 11: 439-49.
20. Chen F, Tan Z, Dong CY, et al. Combination of VEGF(165)/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization. Eur J Pharmacol 2007; 568: 222-30.
21. Kim I, Moon SO, Park SK, Chae SW, Koh GY. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 2001; 89: 477-9.
22. Kim I, Oh JL, Ryu YS, et al. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J, 2002; 16: 126-8.
23. Lemieux C, Maliba R, Favier J, Theoret JF, Merhi Y, Sirois MG. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2005; 105: 1523-30.
24. Hughes DP, Marron MB, Brindle NP. The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ Res 2003; 92: 630-6.
25. Kumar A, Hynes B, Mueen Ahmed K. Natural products as regulator of progenitor cells: Role in cardiovascular regenerative medicine. Pharmacognosy 2009; 1: 28-35.
26. Asahara T. Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration. Handb Exp Pharmacol 2007: 181-94.